Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter December 1, 2020

Comparison of hematological parameters and perinatal outcomes between COVID-19 pregnancies and healthy pregnancy cohort

  • Esin Merve Erol Koç ORCID logo EMAIL logo , Rahime Bedir Fındık , Hatice Akkaya , Işılay Karadağ , Eda Özden Tokalıoğlu and Özlem Moraloğlu Tekin

Abstract

Objectives

To evaluate the relationship between Coronavirus Disease 2019 (COVID-19) in pregnancy and adverse perinatal outcomes. The secondary aim is to analyze the diagnostic value of hematologic parameters in COVID-19 complicated pregnancies.

Methods

The current study is conducted in a high volume tertiary obstetrics center burdened by COVID-19 pandemics, in Turkey. In this cohort study, perinatal outcomes and complete blood count indices performed at the time of admission of 39 pregnancies (Study group) complicated by COVID-19 were compared with 69 uncomplicated pregnancies (Control group).

Results

There was no significant difference between the obstetric and neonatal outcomes of pregnancies with COVID-19 compared to data of healthy pregnancies, except the increased C-section rate (p=0.026). Monocyte count, red cell distribution width (RDW), neutrophil/lymphocyte ratio (NLR), and monocyte/lymphocyte ratio (MLR) were significantly increased (p<0.0001, p=0.009, p=0.043, p<0.0001, respectively) whereas the MPV and plateletcrit were significantly decreased (p=0.001, p=0.008) in pregnants with COVID-19. ROC analysis revealed that the optimal cut-off value for MLR was 0.354 which indicated 96.7% specificity and 59.5% sensitivity in diagnosis of pregnant women with COVID-19. A strong positive correlation was found between the MLR and the presence of cough symptom (r=41.4, p=<0.0001).

Conclusions

The study revealed that, pregnancies complicated by COVID-19 is not related with adverse perinatal outcomes. MLR may serve as a supportive diagnostic parameter together with the Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) in assessment of COVID-19 in pregnant cohort.


Corresponding author: Esin Merve Erol Koc, MD, Obstetrician and Gynecologist, Department of Obstetrics and Gynecology, Ankara State Hospital, Universiteler District, Bilkent Street, No: 106800, Cankaya, Ankara, Turkey, Phone: +90 5054540797, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study protocol was approved by the Institutional Review Board of Ankara City Hospital (#E1-20-672).

References

1. WHO. Coronavirus disease (COVID-19) pandemic. April 9, 2020 [Online]. Geneva: World Health Organization; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed 22 August 2020].Search in Google Scholar

2. Zhao, Z, Liu, J, Wang, J, Xie, T, Zhang, Q, Feng, S, et al.. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection. Int Immunopharm 2017;51:1–8. https://doi.org/10.1016/j.intimp.2017.07.007.Search in Google Scholar PubMed

3. Renshaw, AA, Drago, B, Toraya, N, Gould, EW. Respiratory syncytial virus infection is strongly correlated with decreased mean platelet volume. Int J Infect Dis 2013;17:e678-80. https://doi.org/10.1016/j.ijid.2013.01.012.Search in Google Scholar PubMed

4. Zhang, Y, Zou, P, Gao, H, Yang, M, Yi, P, Gan, J, et al.. Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study. Therapeut Clin Risk Manag 2019;15:911–9. https://doi.org/10.2147/tcrm.s206930.Search in Google Scholar

5. Fei, Y, Zhang, H, Zhang, C. The application of lymphocyte*platelet and mean platelet volume/platelet ratio in influenza A infection in children. J Clin Lab Anal 2019;33:e22995. https://doi.org/10.1002/jcla.22995.Search in Google Scholar PubMed PubMed Central

6. Yang, Z, Shi, J, He, Z, Lu, Y, Xu, Q, Ye, C, et al.. Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients. Aging (NY) 2020;12:6037–48. https://doi.org/10.18632/aging.102999.Search in Google Scholar PubMed PubMed Central

7. Qu, R, Ling, Y, Zhang, YH, Wei, LY, Chen, X, Li, XM, et al.. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol 2020. https://doi.org/10.1002/jmv.25767 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central

8. Peng, J, Qi, D, Yuan, G, Deng, X, Mei, Y, Feng, L, et al.. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): a multicenter, crosssectional study. J Clin Lab Anal 2020. https://doi.org/10.1002/jcla.23475 [Epub ahead of print].Search in Google Scholar PubMed PubMed Central

9. Shah, NM, Lai, PF, Imami, N, Johnson, MR. Progesterone-related immune modulation of pregnancy and labor. Front Endocrinol 2019;10:198. https://doi.org/10.3389/fendo.2019.00198.Search in Google Scholar PubMed PubMed Central

10. WHO. Clinical management of COVID-19, interim guidance [Online]. Geneva: World Health Organization; 2020. Available from: https://apps.who.int/iris/handle/10665/332196 [Accessed 22 Aug 2020].Search in Google Scholar

11. Ruan, Q, Yang, K. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–8. https://doi.org/10.1007/s00134-020-05991-x.Search in Google Scholar PubMed PubMed Central

12. Girija, ASS, Shankar, EM, Larsson, M. Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome? Front Immunol 2020;11:1206. https://doi.org/10.3389/fimmu.2020.01206.Search in Google Scholar PubMed PubMed Central

13. Cheng, B, Jiang, T, Zhang, L, Hu, R, Tian, J, Jiang, Y, et al.. Clinical characteristics of pregnant women with coronavirus disease 2019 in Wuhan, China. Open Forum Infect Dis 2020;7:ofaa294. https://doi.org/10.1093/ofid/ofaa294.Search in Google Scholar

14. Khoury, R, Bernstein, PS, Debolt, C, Stone, J, Sutton, DM, Simpson, LL, et al.. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstet Gynecol 2020;136:273–82. https://doi.org/10.1097/aog.0000000000004025.Search in Google Scholar

15. Dashraath, P, Wong, JLJ, Lim, MXK, Lim, LM, Li, S, Biswas, A, et al.. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521–31. https://doi.org/10.1016/j.ajog.2020.03.021.Search in Google Scholar

16. Narang, K, Enninga, EAL, Gunaratne, M, Ibirogba, ER, Trad, ATA, Elrefaei, A, et al.. SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc 2020;95:1750–65. https://doi.org/10.1016/j.mayocp.2020.05.011.Search in Google Scholar

17. Guan, WJ, Ni, ZY, Hu, Y, Liang, WH, Ou, CQ, He, JX, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. https://doi.org/10.1056/NEJMoa2002032.Search in Google Scholar

18. Huntley, BJF, Huntley, ES, Di Mascio, D, Chen, T, Berghella, V, Chauhan, SP. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol 2020;136:303–12. https://doi.org/10.1097/AOG.0000000000004010.Search in Google Scholar

19. Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3.Search in Google Scholar

20. Yang, AP, Liu, JP, Tao, WQ, Li, HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharm 2020;84:106504. https://doi.org/10.1016/j.intimp.2020.106504.Search in Google Scholar PubMed PubMed Central

21. Liu, F, Zhang, Q, Huang, C, Shi, C, Wang, L, Shi, N, et al.. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics 2020;10:5613–22. https://doi.org/10.7150/thno.45985.Search in Google Scholar PubMed PubMed Central

22. McClain, MT, Park, LP, Nicholson, B, Veldman, T, Zaas, AK, Turner, R, et al.. Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. J Clin Virol 2013;58:689–95. https://doi.org/10.1016/j.jcv.2013.09.015.Search in Google Scholar PubMed

23. Park, GE, Kang, CI. Differential cell count and CRP level in blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak. J Kor Med Sci 2017;32:151–4. https://doi.org/10.3346/jkms.2017.32.1.151.Search in Google Scholar PubMed PubMed Central

24. Beyan, C, Beyan, E. Plateletcrit may not be a marker for recurrent pregnancy loss. Clin Appl Thromb Hemost 2015;21:e588-9. https://doi.org/10.1177/1076029615579100.Search in Google Scholar PubMed

25. Wang, C, Deng, R, Gou, L, Fu, Z, Zhang, X, Shao, F, et al.. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med 2020;8:593. https://doi.org/10.21037/atm-20-3391.Search in Google Scholar PubMed PubMed Central

26. Sharma, D, Dayama, A, Banerjee, S, Bhandhari, S, Chatterjee, A, Chatterjee, D. To study the role of absolute lymphocyte count and RDW in COVID 19 patients and their association with appearance of symptoms and severity. J Assoc Phys India 2020;68:39–42.Search in Google Scholar

27. Sun, S, Cai, X, Wang, H, He, G, Lin, Y, Lu, B, et al.. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020;507:174–80. https://doi.org/10.1016/j.cca.2020.04.024.Search in Google Scholar PubMed PubMed Central

Received: 2020-08-22
Accepted: 2020-11-13
Published Online: 2020-12-01
Published in Print: 2021-02-23

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 19.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpm-2020-0403/html
Scroll to top button